Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1-Infection”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00450580
What this trial is testing

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV-1 Infection
ViiV Healthcare 212
Testing effectiveness (Phase 2)WithdrawnNCT00614640
What this trial is testing

Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT02422797
What this trial is testing

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)

Who this might be right for
HIV Infections
ViiV Healthcare 518
Testing effectiveness (Phase 2)Ended earlyNCT00095576
What this trial is testing

Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)

Who this might be right for
AIDSHIV Infections
Merck Sharp & Dohme LLC 3,000
Testing effectiveness (Phase 2)Study completedNCT01803074
What this trial is testing

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 107
Testing effectiveness (Phase 2)Study completedNCT00081588
What this trial is testing

An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

Who this might be right for
HIV Infection
Tibotec Pharmaceuticals, Ireland 555
Testing effectiveness (Phase 2)Study completedNCT00000820
What this trial is testing

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 104
Not applicableLooking for participantsNCT07725042
What this trial is testing

Analyses of Newly Diagnosed HIV Infection in Hong Kong

Who this might be right for
HIV -1 Infection
Chinese University of Hong Kong 720
Not applicableStudy completedNCT00016588
What this trial is testing

Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Gilead Sciences
Early research (Phase 1)Study completedNCT00040274
What this trial is testing

DPC 817 in HIV-Infected Males

Who this might be right for
HIV Infections
Pharmasset 30
Post-approval studies (Phase 4)UnknownNCT00120419
What this trial is testing

Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)

Who this might be right for
HIV Infection
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07655128
What this trial is testing

Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life

Who this might be right for
HIV -1 Infection
Hospital Universitario 12 de Octubre 87
Testing effectiveness (Phase 2)Study completedNCT00036465
What this trial is testing

Effects of Changing HIV Therapy at Lower Versus Higher Viral Loads

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT00857311
What this trial is testing

MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 17
Not applicableUnknownNCT05064020
What this trial is testing

Bictegravir in the Elderly Living With HIV (BICEP)

Who this might be right for
HIV-1-infection
State University of New York at Buffalo 162
Large-scale testing (Phase 3)Study completedNCT00002123
What this trial is testing

A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3

Who this might be right for
HIV Infections
Pharmacia and Upjohn
Not applicableStudy completedNCT03187964
What this trial is testing

Xpert Ultra and Xpert HIV-VL in People Living With HIV

Who this might be right for
HIV/AIDSTB - TuberculosisAntiretroviral Therapy, Highly Active
University of Stellenbosch 1,053
Not applicableStudy completedNCT00002375
What this trial is testing

Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 24
Not applicableStudy completedNCT00456664
What this trial is testing

CMV Disease and IRIS in HIV-1 Infected Persons

Who this might be right for
HIV InfectionsCytomegalovirus
Kaohsiung Medical University Chung-Ho Memorial Hospital 200
Large-scale testing (Phase 3)Study completedNCT01709084
What this trial is testing

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Who this might be right for
Human Immunodeficiency Virus-type 1 Infection
Janssen-Cilag International NV 426
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation